NO973921L - Parenterale farmasöytiske sammensetninger inneholdende ammoniumalkylsalter av 2-arylpropionsyrer - Google Patents

Parenterale farmasöytiske sammensetninger inneholdende ammoniumalkylsalter av 2-arylpropionsyrer Download PDF

Info

Publication number
NO973921L
NO973921L NO973921A NO973921A NO973921L NO 973921 L NO973921 L NO 973921L NO 973921 A NO973921 A NO 973921A NO 973921 A NO973921 A NO 973921A NO 973921 L NO973921 L NO 973921L
Authority
NO
Norway
Prior art keywords
ketoprofen
salt
pharmaceutical composition
composition according
fact
Prior art date
Application number
NO973921A
Other languages
English (en)
Norwegian (no)
Other versions
NO973921D0 (no
Inventor
Marco Gentile
Luigi Boltri
Gaetano Clavenna
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of NO973921D0 publication Critical patent/NO973921D0/no
Publication of NO973921L publication Critical patent/NO973921L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973921A 1995-12-28 1997-08-26 Parenterale farmasöytiske sammensetninger inneholdende ammoniumalkylsalter av 2-arylpropionsyrer NO973921L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002777A IT1277741B1 (it) 1995-12-28 1995-12-28 Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
PCT/IB1996/001461 WO1997024114A1 (en) 1995-12-28 1996-12-23 Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids

Publications (2)

Publication Number Publication Date
NO973921D0 NO973921D0 (no) 1997-08-26
NO973921L true NO973921L (no) 1997-08-26

Family

ID=11372830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973921A NO973921L (no) 1995-12-28 1997-08-26 Parenterale farmasöytiske sammensetninger inneholdende ammoniumalkylsalter av 2-arylpropionsyrer

Country Status (23)

Country Link
US (1) US5895789A (de)
EP (1) EP0814797B1 (de)
KR (1) KR19980702301A (de)
CN (1) CN1082812C (de)
AR (1) AR005308A1 (de)
AT (1) ATE232096T1 (de)
AU (1) AU1069897A (de)
BR (1) BR9607422A (de)
CA (1) CA2213232A1 (de)
CZ (1) CZ290646B6 (de)
DE (1) DE69626103T2 (de)
DK (1) DK0814797T3 (de)
EA (1) EA000599B1 (de)
ES (1) ES2192234T3 (de)
HU (1) HU224685B1 (de)
IT (1) IT1277741B1 (de)
NO (1) NO973921L (de)
PL (1) PL187170B1 (de)
PT (1) PT814797E (de)
SI (1) SI9620023A (de)
SK (1) SK282579B6 (de)
TR (1) TR199700869T1 (de)
WO (1) WO1997024114A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298214B1 (it) * 1998-01-28 1999-12-20 Dompe Spa Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ES2189682B1 (es) * 2001-12-11 2004-04-01 Laboratorios Del Dr. Esteve, S.A. Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.
CN1329029C (zh) * 2002-10-25 2007-08-01 冬姆佩制药股份公司 含有2－芳基丙酸盐的无痛可注射组合物
US7090859B2 (en) * 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
EP1603548A4 (de) * 2003-02-05 2007-10-10 Myriad Genetics Inc Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1745180A1 (de) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Frontverkleidung für stützwände
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2606947A1 (en) * 2005-04-28 2006-11-02 Theraquest Biosciences Llc Methods and compositions for treating pain
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
BRPI0707698A2 (pt) * 2006-02-06 2011-05-10 Pharmaceutical Solutions Inc preparaÇÕes nço esteroidais antiinflamatàrias orais lÍquidas e em pà para administraÇço a animais
MX2008011823A (es) * 2006-03-16 2008-10-31 Novartis Ag Forma de dosificacion solida que contiene un agente activo de sabor encubierto.
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
FR2971712B1 (fr) * 2011-02-22 2016-06-10 Map France Solution stable de ketoprofene pour injection intraveineuse
US8415337B1 (en) 2011-03-06 2013-04-09 Recordati Rare Diseases Inc. Ibuprofen compositions and methods of making same
CN102381986A (zh) * 2011-07-25 2012-03-21 南京特丰药业股份有限公司 一种右旋布洛芬氨丁三醇盐及其口服溶液的制备方法
ES2600153T3 (es) * 2011-08-04 2017-02-07 Omeros Corporation Soluciones antiinflamatorias estables para inyección
CN102362857A (zh) * 2011-11-22 2012-02-29 陆荣政 一种右旋布洛芬注射液及其制备方法
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
CN111526868A (zh) 2017-11-30 2020-08-11 方济各安吉利克化学联合股份有限公司 酮洛芬及其盐和对映体的稳定的液体组合物
EP3670489A1 (de) 2018-12-21 2020-06-24 Dompé farmaceutici S.p.A. Cokristall von ketoprofen, zusammensetzungen damit, verfahren zur herstellung davon und verwendungen davon
EP3842408A1 (de) 2019-12-23 2021-06-30 Dompé farmaceutici S.p.A. Co-kristall von ketoprofen und dessen herstellung, pharmazeutische zusammensetzungen damit und verwendungen davon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
DE2830921A1 (de) * 1978-07-14 1980-01-31 Bbc Brown Boveri & Cie Verfahren zum verhindern von sintererscheinungen an schmiedebloeckchen
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3270988D1 (en) * 1981-07-20 1986-06-12 Upjohn Co Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
DE3639038C2 (de) * 1986-11-14 1997-02-06 Helmut Dr Lukas Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4887620A (en) * 1988-04-26 1989-12-19 Better Life International, Inc. Composition and method to provide organoleptic bite in a composition for human consumption
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
FR2687915B1 (fr) * 1992-02-28 1995-05-05 Rhone Poulenc Rorer Sa Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
AU6290594A (en) * 1993-03-09 1994-09-26 Dompe Farmaceutici S.P.A. Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ATE232096T1 (de) 2003-02-15
CZ290646B6 (cs) 2002-09-11
CN1176596A (zh) 1998-03-18
TR199700869T1 (xx) 1997-12-21
DE69626103D1 (de) 2003-03-13
HU224685B1 (hu) 2005-12-28
WO1997024114A1 (en) 1997-07-10
CZ264397A3 (en) 1997-11-12
SI9620023A (sl) 1998-02-28
DK0814797T3 (da) 2003-05-26
ES2192234T3 (es) 2003-10-01
DE69626103T2 (de) 2003-12-04
CN1082812C (zh) 2002-04-17
KR19980702301A (ko) 1998-07-15
US5895789A (en) 1999-04-20
SK113097A3 (en) 1998-02-04
HUP9801048A3 (en) 2000-07-28
SK282579B6 (sk) 2002-10-08
PT814797E (pt) 2003-06-30
CA2213232A1 (en) 1997-07-10
ITMI952777A0 (de) 1995-12-28
HUP9801048A1 (hu) 1998-10-28
ITMI952777A1 (it) 1997-06-28
BR9607422A (pt) 1998-06-23
EP0814797B1 (de) 2003-02-05
AR005308A1 (es) 1999-04-28
IT1277741B1 (it) 1997-11-12
AU1069897A (en) 1997-07-28
PL322165A1 (en) 1998-01-19
MX9706237A (es) 1997-11-29
NO973921D0 (no) 1997-08-26
EP0814797A1 (de) 1998-01-07
EA199700201A1 (ru) 1998-02-26
EA000599B1 (ru) 1999-12-29
HK1008777A1 (en) 1999-07-16
PL187170B1 (pl) 2004-05-31

Similar Documents

Publication Publication Date Title
NO973921L (no) Parenterale farmasöytiske sammensetninger inneholdende ammoniumalkylsalter av 2-arylpropionsyrer
CA2125644C (en) Pharmaceutical compositions containing the salts of s(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
US20080139518A1 (en) Topical compositions for treatment of skin conditions
EP0710108B1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
EP1443902A2 (de) Verfahren zur herstellung von stabilen lösungen phenolischer substanzen und resultierende lösungen
EP3590514A1 (de) Medizinische zubereitung
NO309175B1 (no) Transdermalt terapeutisk system med virkestoffet acetylsalicylsyre
US4962124A (en) Onset-hastened/enhanced antipyretic response
NO970881L (no) Krystallinsk D-vitaminderivat
ES2286864T3 (es) Derivados de la taurina para el tratamiento de trastornos oftalmicos.
JPS63215641A (ja) ゼラチン皮膜組成物
US5286751A (en) Sustained/enhanced antipyretic response
MXPA97006237A (en) Parenteral pharmaceutical compositions containing 2-arilpropion acid alkylamone salts
CN100350905C (zh) 烧伤的治疗
KR102478284B1 (ko) 덱시부프로펜 함유 주사용 액상 조성물
CN120936351A (zh) 任选地与n-酰基乙醇胺组合地包含3,4-亚甲基二氧基甲基苯丙胺的组合物及其用途

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application